APA (7th ed.) Citation

J, P., YY, C., JJ, C., J, A., RW, C. Y., JD, O., . . . MJ, T. (2025). MYC plus class IIa HDAC inhibition drives mitochondrial dysfunction in non-small cell lung cancer. Cell reports, 44(6), 115722. https://doi.org/10.1016/j.celrep.2025.115722

Chicago Style (17th ed.) Citation

J, Park, Chen YY, Cao JJ, An J, Chiu Yen RW, Outen JD, Baylin SB, and Topper MJ. "MYC Plus Class IIa HDAC Inhibition Drives Mitochondrial Dysfunction in Non-small Cell Lung Cancer." Cell Reports 44, no. 6 (2025): 115722. https://doi.org/10.1016/j.celrep.2025.115722.

MLA (9th ed.) Citation

J, Park, et al. "MYC Plus Class IIa HDAC Inhibition Drives Mitochondrial Dysfunction in Non-small Cell Lung Cancer." Cell Reports, vol. 44, no. 6, 2025, p. 115722, https://doi.org/10.1016/j.celrep.2025.115722.